Naga MounikaDrug Product · Validation · CMC
Menu
Working document

Redundant (Serial) Filtration Validation Plan

A plug-and-play validation plan for two sterilizing-grade filters run in series, forcing each position onto its own bacterial retention and integrity test record and stating the combined-system versus independent sterility claim, with a filled specimen.

Document typePlan
Topic areaDrug Product
LevelAdvanced
UpdatedSeptember 2026
How to use this document

Copy the template below into your quality system. Replace every <<FILL: ...>> placeholder with your company, system, and process specifics, then route it through your own document control, review, and approval. The filled specimen shows one worked example; adapt the numbers and scope to your operation and verify each cited regulation or standard against the current source before you rely on it.

This is a generic, originally worded starting point. It contains no confidential, proprietary, or employer material, it is drafted with AI assistance and reviewed, it is not legal or compliance advice, and adopting it does not by itself create or prove compliance. See the Disclaimer and Terms.

This is a ready-to-use validation plan for two sterilizing-grade filters run in series, built to prevent the common gap where only one position in a redundant pair carries its own bacterial retention and integrity test validation. Replace every <<FILL: ...>> placeholder with your own specifics and route it through your normal document control, review, and approval. A worked filled specimen follows. Verify each cited reference against the current source before you rely on it.

Document control header

FieldEntry
Document titleRedundant Filtration Validation Plan for <<FILL: product / process step>>
Document number<<FILL: e.g. RFV-2026-01>>
Version<<FILL>>
Effective date<<FILL>>
Upstream filter model<<FILL>>
Downstream filter model<<FILL>>
Plan owner<<FILL: e.g. Validation Lead>>

1. Purpose

This plan defines how each position in a two-filter series is independently validated for bacterial retention and physical integrity, and states whether the sterility claim for <<FILL: product>> rests on the combined system or on each filter independently.

2. Scope

DimensionDecision
Product / process step<<FILL>>
Reason redundancy was adopted<<FILL: e.g. batch cannot be remade, patient-specific drug substance>>
Out of scope<<FILL: e.g. prefilters upstream of this pair, validated separately>>

3. Responsibilities

RoleResponsibility
Sponsor validation leadOwns this plan, confirms both positions are independently challenged.
Filter manufacturer(s)Execute each position’s bacterial retention challenge under its own worst-case parameters.
Manufacturing / operationsPerforms routine integrity testing at both positions per the validated method.
Quality AssuranceApproves the plan and the combined-system versus independent-basis sterility claim.

4. Sterility claim basis

FieldEntry
Basis selected<<FILL: combined-system / independent-per-filter>>
Rationale<<FILL: state why this basis was chosen and what it means for a single failed integrity test at either position>>

5. Per-position validation requirements

RequirementUpstream filterDownstream filter
Bacterial retention study (ASTM F838), own worst-case parameters<<FILL>><<FILL>>
Bioburden/particulate load actually seen at this position (may differ upstream vs. downstream)<<FILL>><<FILL>>
Physical integrity test method and correlation study<<FILL>><<FILL>>
PUPSIT performed at this position, or risk-based omission justified (reference the paired PUPSIT Risk-Based Justification)<<FILL>><<FILL>>

6. Acceptance criteria

CriterionRequirement
Both positions independently retention-testedNo position relies on the other’s data as its own basis
Both positions have their own integrity test correlationProduction limit for each position set with margin on the safe side of its own retentive population
Sterility claim basis stated and approvedCombined-system or independent-per-filter, per section 4, before routine manufacture begins

7. Deviation handling

A failed integrity test or an out-of-specification retention result at either position is a deviation regardless of the other position’s result. State in the deviation record whether the sterility claim basis in section 4 allows the batch disposition sought, or whether an independent-basis claim requires treating the failure as batch-affecting regardless of the other filter’s performance.

8. Summary and conclusion

State plainly whether both positions are qualified, what the approved sterility claim basis is, and whether routine manufacture may proceed on this basis.

9. References

ASTM F838, Standard Test Method for Determining Bacterial Retention of Membrane Filters Utilized for Liquid Filtration. PDA Technical Report No. 26, Sterilizing Filtration of Liquids. EU GMP Annex 1 (2022), Manufacture of Sterile Medicinal Products.

Confirm the current version of each reference before issue.

10. Revision history

VersionDateAuthorSummary of change
<<FILL: 1.0>><<FILL>><<FILL>>Initial issue.

11. Approvals

RoleNameSignatureDate
Author (Validation lead)<<FILL>>
Reviewer (Manufacturing)<<FILL>>
Approver (QA)<<FILL>>

Filled specimen

Extract for an example patient-specific cell therapy fill step where the batch cannot be remade. Company, product, and numbers are illustrative.

FieldEntry
Product / process stepAcme Therapeutics ATX-520 autologous cell therapy, final drug product fill
Reason for redundancySingle-patient batch; drug substance cannot be regenerated if the batch is lost
Sterility claim basisIndependent-per-filter; a failed integrity test at either position fails the batch regardless of the other position’s result, given the irreplaceable nature of the batch
Upstream filterOwn ASTM F838 challenge at the upstream worst-case bioburden load (higher, given proximity to the open processing step); diffusive flow correlation study RFV-018-U
Downstream filterOwn ASTM F838 challenge at the downstream worst-case parameters; diffusive flow correlation study RFV-018-D
PUPSITPerformed at the downstream position only, with engineering controls; risk-based omission at the upstream position justified by very small batch volume and documented in the paired PUPSIT justification, reassessed per position

Both positions passed their independent retention and integrity correlation studies. Conclusion: both filters qualified on an independent-per-filter sterility claim basis; routine manufacture may proceed under this plan.

Common inspection findings this plan prevents

  • A redundant pair where only the downstream filter carries a bacterial retention study, the upstream filter assumed covered by “redundancy.”
  • No stated basis for whether the sterility claim rests on the combined system or on each filter independently.
  • PUPSIT considered once for the pair rather than assessed at each position separately.
  • A failed integrity test at one position dispositioned without reference to the approved sterility claim basis.

How to adapt this plan

  1. Set your document number, filter models, and the reason redundancy was adopted in the header.
  2. Decide and document the sterility claim basis in section 4 before either position is tested.
  3. Populate section 5 with each position’s own bioburden/particulate reality; do not assume they match.
  4. Reference the paired PUPSIT justification separately for each position where PUPSIT applies.
Add this site to your home screen Full screen, works offline, one tap from your home screen.